Staphylococcus aureus nasal carriage and bloodstream infection among conventional hemodialysis patients in Thailand: a prospective multicenter cohort study

BMC Res Notes. 2022 Sep 6;15(1):290. doi: 10.1186/s13104-022-06185-y.

Abstract

Objective: Staphylococcus aureus nasal carriage screening among hemodialysis patients is not standard practice in Thailand, because of data lacking regarding prevalence and correlation with subsequent infection. We aimed to investigate the prevalence of S. aureus nasal carriage and its association with bloodstream infection among hemodialysis patients. In this prospective multicenter cohort study, participants were screened for S. aureus nasal carriage over 2 consecutive weeks. Incidence of S. aureus bloodstream infection over the next 12 months was observed.

Results: The prevalence of S. aureus nasal carriage was 11.67%. Incidence of S. aureus bacteremia among participants with and without S. aureus nasal carriage were 7.1% and 3.8%, respectively. The odds ratio for nasal carriage and subsequent bacteremia was 1.96 (95% CI 0.04-21.79; p = 0.553). Survival analysis showed that time to bacteremia among participants in the two groups did not significantly differ (p = 0.531). Prevalence of S. aureus nasal carriage among hemodialysis patients in Thailand was low. Patients presenting with S. aureus nasal carriage did not have increased risk of S. aureus bacteremia after 12-month follow-up. Nasal S. aureus screening and decolonization should not be encouraged in this setting.

Keywords: End-stage chronic kidney disease; Hemodialysis; S. aureus bloodstream infection; S. aureus nasal carriage.

Publication types

  • Multicenter Study

MeSH terms

  • Bacteremia* / epidemiology
  • Bacteremia* / etiology
  • Carrier State / epidemiology
  • Cohort Studies
  • Humans
  • Prevalence
  • Prospective Studies
  • Renal Dialysis / adverse effects
  • Staphylococcal Infections* / epidemiology
  • Staphylococcus aureus
  • Thailand / epidemiology